Responsible Investor

Login | Subscribe | Trial

Not a subscriber? Click here for a Free Trial

Features

The US opioid crisis: An investor antidote

The US opioid crisis: An investor antidote »

With law suits piling up and politicians wading in, what is in store for firms involved in US opioids?

FREE Disappearing IPOs and trading Unicorns: a tale of market and governance danger

The rise in secondary market trading for private companies could have serious consequences for the public markets, transparency and investor governance.

FREE Comment: Legal implications are no reason to vote against Follow This resolution at Shell

Client Earth’s Alice Garton offers a legal perspective on next week’s vote

FREE Comment: Investors must put their money where their mouth is and back Follow This

Sponsored Content

  SDGsIntegrating the Sustainable Development Goals into Investment Portfolios

Engagement on lobbying: Forget the votes, what about the withdrawals?

FREE Pay-for-success: The latest thinking on social impact bonds

FREE Comment: Bond vigilantes and climate change